- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
A CBO report indicates 23 million would lose health coverage by 2026.
The disputed health care repeal bill pushed by Republican congress members received an updated review from the nonpartisan Congressional Budget Office, three weeks after it was put to a vote.
The CBO score revealed 23 million people would lose insurance within the next decade thanks to the American health Care Act.
“In 2026, an estimated 51 million people under age 65 would be uninsured, compared with 28 million who would lack insurance that year under [Obamacare],” read the report.
CBO’s big findings, in chart form, from @haeyoun and @KevinQ https://t.co/HGZFUSY29x pic.twitter.com/Hg9t7dftsp
— Margot Sanger-Katz (@sangerkatz) May 24, 2017
The proposed bill would cause a reduction in the federal budget by $119 billion over the next decade. “That is $32 billion less in net savings projected to be achieved under an earlier version of the bill,” per CNBC.
Response from top GOP members
Health Human Services Secretary Tom Price attacked the CBO score following its reveal.
“The CBO was wrong when they analyzed Obamacare’s effect on cost and coverage, and they are wrong again,” Price said in a statement.
On the other hand, House Speaker Paul Ryan seemed content with the results.
“This CBO report again confirms that the American Health Care Act achieves our mission: lowering premiums and lowering the deficit,” the speaker said in a statement following the announcement.
A CBO score is used as a template for the reach and impact of any proposed bill from the US Congress. Back in [date] members of the house re-introduced a new version of the Obamacare-repeal and forced a vote on the floor despite not having a revised score.
Earlier in May, the vote on the bill narrowly moved it up to the Senate, where it’s expected to undergo substantial changes to its most problematic elements. It was revealed some congress members voted on the bill despite not reading it entirely.
The decision to push through this legislation without an official score appeared odd and inappropriate to Democratic members of congress.
Investor Takeaway
Despite the presidency, control of both Senate and Congress, Republicans can’t seem to put together a viable bill to complete a repeal promise on Obamacare. It seems likely the path to tax reform will also be rocky and many analysts have already expressed doubt in the capability of this administration to pass this crucial amendment.
The CBO score also reveals how rushed the bill was and how much work GOP senators have ahead to get a bill that would prevent these heavy losses in insurance.
Don’t forget to follow @INN_LifeScience for real-time updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.